Hendifar A - Search Results

1

Moving Beyond Conventional Clinical Trial End Points in Treatment-refractory Metastatic Colorectal Cancer: A Composite Quality-of-life and Symptom Control End Point.

Gong J, Wu D, Chuang J, Tuli R, Simard J, Hendifar A. Gong J, et al. Among authors: hendifar a. Clin Ther. 2017 Nov;39(11):2135-2145. doi: 10.1016/j.clinthera.2017.09.015. Epub 2017 Oct 25. Clin Ther. 2017. PMID: 29079389 Review.

2

Gender disparities in metastatic colorectal cancer survival.

Hendifar A, Yang D, Lenz F, Lurje G, Pohl A, Lenz C, Ning Y, Zhang W, Lenz HJ. Hendifar A, et al. Clin Cancer Res. 2009 Oct 15;15(20):6391-7. doi: 10.1158/1078-0432.CCR-09-0877. Epub 2009 Sep 29. Clin Cancer Res. 2009. PMID: 19789331 Free PMC article.

3

Biomarker-driven EGFR therapy improves outcomes in patients with metastatic colorectal cancer.

Hendifar A, Tan CR, Annamalai A, Tuli R. Hendifar A, et al. Expert Rev Anticancer Ther. 2014 Sep;14(9):1051-61. doi: 10.1586/14737140.2014.922881. Epub 2014 Jun 5. Expert Rev Anticancer Ther. 2014. PMID: 24898788 Review.

4

Dosimetric evaluation of simultaneous integrated boost during stereotactic body radiation therapy for pancreatic cancer.

Yang W, Reznik R, Fraass BA, Nissen N, Hendifar A, Wachsman A, Sandler H, Tuli R. Yang W, et al. Among authors: hendifar a. Med Dosim. 2015 Spring;40(1):47-52. doi: 10.1016/j.meddos.2014.09.001. Epub 2014 Oct 22. Med Dosim. 2015. PMID: 25445989 Clinical Trial.

5

Review of systemic therapies for locally advanced and metastatic rectal cancer.

Yaffee P, Osipov A, Tan C, Tuli R, Hendifar A. Yaffee P, et al. Among authors: hendifar a. J Gastrointest Oncol. 2015 Apr;6(2):185-200. doi: 10.3978/j.issn.2078-6891.2014.112. J Gastrointest Oncol. 2015. PMID: 25830038 Free PMC article. Review.

6

Influence of Body Mass Index and Albumin on Perioperative Morbidity and Clinical Outcomes in Resected Pancreatic Adenocarcinoma.

Hendifar A, Osipov A, Khanuja J, Nissen N, Naziri J, Yang W, Li Q, Tuli R. Hendifar A, et al. PLoS One. 2016 Mar 25;11(3):e0152172. doi: 10.1371/journal.pone.0152172. eCollection 2016. PLoS One. 2016. PMID: 27015568 Free PMC article.

7

Impact of margin status and lymphadenectomy on clinical outcomes in resected pancreatic adenocarcinoma: implications for adjuvant radiotherapy.

Osipov A, Naziri J, Hendifar A, Dhall D, Rutgers JK, Chopra S, Li Q, Tighiouart M, Annamalai A, Nissen NN, Tuli R. Osipov A, et al. Among authors: hendifar a. J Gastrointest Oncol. 2016 Apr;7(2):239-47. doi: 10.3978/j.issn.2078-6891.2015.109. J Gastrointest Oncol. 2016. PMID: 27034792 Free PMC article.

8

Targeting mTOR in Pancreatic Ductal Adenocarcinoma.

Iriana S, Ahmed S, Gong J, Annamalai AA, Tuli R, Hendifar AE. Iriana S, et al. Front Oncol. 2016 Apr 25;6:99. doi: 10.3389/fonc.2016.00099. eCollection 2016. Front Oncol. 2016. PMID: 27200288 Free PMC article. Review.

9

Identifying prognostic intratumor heterogeneity using pre- and post-radiotherapy 18F-FDG PET images for pancreatic cancer patients.

Yue Y, Osipov A, Fraass B, Sandler H, Zhang X, Nissen N, Hendifar A, Tuli R. Yue Y, et al. Among authors: hendifar a. J Gastrointest Oncol. 2017 Feb;8(1):127-138. doi: 10.21037/jgo.2016.12.04. J Gastrointest Oncol. 2017. PMID: 28280617 Free PMC article.

10

Redefining the Positive Margin in Pancreatic Cancer: Impact on Patterns of Failure, Long-Term Survival and Adjuvant Therapy.

Osipov A, Nissen N, Rutgers J, Dhall D, Naziri J, Chopra S, Li Q, Hendifar AE, Tuli R. Osipov A, et al. Among authors: hendifar ae. Ann Surg Oncol. 2017 Nov;24(12):3674-3682. doi: 10.1245/s10434-017-6076-z. Epub 2017 Sep 5. Ann Surg Oncol. 2017. PMID: 28871564

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters